uniQure
QURE
$4.67
Share price
-0.85%
Change (1 day)
-76.12%
Change (1 year)
uniQure (QURE) - Total assets
Total assets on the balance sheet as of December 2023 : $0.83 B
According to uniQure's latest financial reports the company's total assets are $0.83 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
uniQure - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.83 B | 17.98% |
| 2022-12-31 | $0.70 B | -12.88% |
| 2021-12-31 | $0.80 B | 137.72% |
| 2020-12-31 | $0.34 B | -24.13% |
| 2019-12-31 | $0.44 B | 63.79% |
| 2018-12-31 | $0.27 B | 30.65% |
| 2017-12-31 | $0.20 B | 10.19% |
| 2016-12-31 | $0.19 B | -27.56% |
| 2015-12-31 | $0.26 B | 125.51% |
| 2014-12-31 | $0.11 B | 116.45% |
| 2013-12-31 | $53.81 M | 630.89% |
| 2012-12-31 | $7.36 M | -2.13% |
| 2011-12-31 | $7.52 M | -75.09% |
| 2010-12-31 | $30.19 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $97.15 B | 11,581.53% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 16,711.09% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $0.16 B | -80.12% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.61 B | -26.22% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 722.62% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.62 B | -24.42% | 🇺🇸 USA |